Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms

CHU de Reims250 enrolled

Overview

Endovascular treatment of ruptured and unruptured intracranial aneurysms presents complications, mainly the thrombo-embolic complication. No specific studies have been conducted to study factors associated with the occurrence of thromboembolic complications (symptomatic or not) post endovascular treatment of intracranial aneurysms.

In this multicenter, prospective study, patients with treatment of unruptured intracranial aneurysms will be recruited. The thromboembolic complications will be research using diffusion-weighted MRI.

Study Type

INTERVENTIONAL

Allocation

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

250

Conditions

Unruptured Intracranial Aneurysms

Interventions

diffusion-weighted MRI and clinical examinationOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patient having a programmed endovascular treatment for unruptured intracranial aneurysm * patient older than 18 years * patient consenting to participate to the study * patient enrolled in the national healthcare insurance program Exclusion Criteria: * patients with contraindications for MRI * patients whose clinical condition does not allow sufficient cooperation to the realization of MRI * patients with arteriovenous malformation intracranial

Locations (1)

Chu de Reims

Reims, France

Outcomes

Primary Outcomes

Thromboembolic complication

Thromboembolic complication diagnosed using diffusion-weighted MRI

Time frame: 72 hours after endovascular treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.